{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:04:23Z","timestamp":1762459463310},"reference-count":162,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institutes of Aging","award":["1R15AG050292"],"award-info":[{"award-number":["1R15AG050292"]}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["NPSPAD 247219"],"award-info":[{"award-number":["NPSPAD 247219"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","nrjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition Research"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.nutres.2016.11.002","type":"journal-article","created":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T15:47:11Z","timestamp":1478620031000},"page":"1305-1315","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease"],"prefix":"10.1016","volume":"36","author":[{"given":"John","family":"Grizzanti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyoung-Gon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Camins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merce","family":"Pallas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma","family":"Casadesus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nutres.2016.11.002_bb0005","series-title":"Prevalence of Overweight, Obesity, and Extreme Obesity Among Adults: United States, 1960\u20131962 Through 2011\u20132012","first-page":"1","author":"Fryar","year":"2014"},{"issue":"8","key":"10.1016\/j.nutres.2016.11.002_bb0010","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1001\/jamainternmed.2015.2405","article-title":"Prevalence of Overweight and Obesity in the United States, 2007-2012","volume":"175","author":"Yang","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.nutres.2016.11.002_bb0015","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1046\/j.1365-2648.2001.2016c.x","article-title":"Fast food nation: What the All-American meal is doing to the world","volume":"36","author":"Ineichen","year":"2001","journal-title":"J Adv Nurs"},{"issue":"1","key":"10.1016\/j.nutres.2016.11.002_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jacl.2014.12.002","article-title":"JCL Roundtable: Fast Food and the American Diet","volume":"9","author":"Brown","year":"2015","journal-title":"J Clin Lipidol"},{"issue":"9","key":"10.1016\/j.nutres.2016.11.002_bb0025","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa0804748","article-title":"Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates","volume":"360","author":"Sacks","year":"2009","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.nutres.2016.11.002_bb0030","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/oby.2003.162","article-title":"Labor saved, calories lost: the energetic impact of domestic labor\u2010saving devices","volume":"11","author":"Lanningham\u2010Foster","year":"2003","journal-title":"Obes Res"},{"issue":"9986","key":"10.1016\/j.nutres.2016.11.002_bb0035","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1016\/S0140-6736(14)61748-7","article-title":"Management of obesity: improvement of health-care training and systems for prevention and care","volume":"385","author":"Dietz","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.nutres.2016.11.002_bb0040","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/oby.21068","article-title":"A national survey of public views about the classification of obesity as a disease","volume":"23","author":"Puhl","year":"2015","journal-title":"Obesity"},{"issue":"4","key":"10.1016\/j.nutres.2016.11.002_bb0045","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.eururo.2014.06.036","article-title":"Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030","volume":"66","author":"Antonelli","year":"2014","journal-title":"Eur Urol"},{"issue":"19","key":"10.1016\/j.nutres.2016.11.002_bb0050","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1001\/jama.2015.4260","article-title":"Prevalence of the metabolic syndrome in the United States, 2003-2012","volume":"313","author":"Aguilar","year":"2015","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.nutres.2016.11.002_bb0055","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1001\/jama.282.16.1523","article-title":"The disease burden associated with overweight and obesity","volume":"282","author":"Must","year":"1999","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.nutres.2016.11.002_bb0060","first-page":"1","article-title":"Obesity among adults in the United States--no statistically significant change since 2003-2004","author":"Ogden","year":"2007","journal-title":"NCHS Data Brief"},{"issue":"3","key":"10.1016\/j.nutres.2016.11.002_bb0065","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11011-013-9412-4","article-title":"Neurodegenerative disease and obesity: what is the role of weight loss and bariatric interventions?","volume":"28","author":"Ashrafian","year":"2013","journal-title":"Metab Brain Dis"},{"issue":"9","key":"10.1016\/j.nutres.2016.11.002_bb0070","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1177\/1352458512436596","article-title":"High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women","volume":"18","author":"Hedstr\u00f6m","year":"2012","journal-title":"Mult Scler J"},{"issue":"20","key":"10.1016\/j.nutres.2016.11.002_bb0075","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJM200011163432001","article-title":"Relapses and progression of disability in multiple sclerosis","volume":"343","author":"Confavreux","year":"2000","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.nutres.2016.11.002_bb0080","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1212\/WNL.0b013e31828154f3","article-title":"Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome","volume":"80","author":"Langer-Gould","year":"2013","journal-title":"Neurology"},{"issue":"19","key":"10.1016\/j.nutres.2016.11.002_bb0085","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1212\/WNL.0b013e3181c0d4b6","article-title":"Adiposity indicators and dementia over 32 years in Sweden","volume":"73","author":"Gustafson","year":"2009","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/j.nutres.2016.11.002_bb0090","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1212\/01.wnl.0000306313.89165.ef","article-title":"Central obesity and increased risk of dementia more than three decades later","volume":"71","author":"Whitmer","year":"2008","journal-title":"Neurology"},{"issue":"7504","key":"10.1016\/j.nutres.2016.11.002_bb0095","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/bmj.38446.466238.E0","article-title":"Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study","volume":"330","author":"Whitmer","year":"2005","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.nutres.2016.11.002_bb0100","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/156720507780362047","article-title":"Body mass index in midlife and risk of Alzheimer disease and vascular dementia","volume":"4","author":"Whitmer","year":"2007","journal-title":"Curr Alzheimer Res"},{"issue":"10","key":"10.1016\/j.nutres.2016.11.002_bb0105","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/archneur.62.10.1556","article-title":"Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease","volume":"62","author":"Kivipelto","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nutres.2016.11.002_bb0110","series-title":"65 Years and Over Population: 2000: Census 2000 Brief","author":"Hetzel","year":"2008"},{"key":"10.1016\/j.nutres.2016.11.002_bb0115","series-title":"Age: 2000: census 2000 brief","author":"Meyer","year":"2008"},{"issue":"3","key":"10.1016\/j.nutres.2016.11.002_bb0120","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1525-1373.1999.d01-140.x","article-title":"Antioxidants, oxidative stress, and degenerative neurological disorders","volume":"222","author":"Floyd","year":"1999","journal-title":"Exp Biol Med"},{"issue":"2","key":"10.1016\/j.nutres.2016.11.002_bb0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0167-4943(91)90025-L","article-title":"Age influence on oxidative events during brain ischemia\/reperfusion","volume":"12","author":"Floyd","year":"1991","journal-title":"Arch Gerontol Geriatr"},{"issue":"S1","key":"10.1016\/j.nutres.2016.11.002_bb0130","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1002\/ana.410320706","article-title":"Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress","volume":"32","author":"Floyd","year":"1992","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.nutres.2016.11.002_bb0135","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1152\/physrev.1994.74.1.139","article-title":"Cellular defenses against damage from reactive oxygen species","volume":"74","author":"Yu","year":"1994","journal-title":"Physiol Rev"},{"issue":"10","key":"10.1016\/j.nutres.2016.11.002_bb0140","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0899-9007(02)00916-4","article-title":"Free radicals, antioxidants, and nutrition","volume":"18","author":"Fang","year":"2002","journal-title":"Nutrition"},{"issue":"8","key":"10.1016\/j.nutres.2016.11.002_bb0145","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0028-3908(01)00019-3","article-title":"Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier","volume":"40","author":"Gilgun-Sherki","year":"2001","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.nutres.2016.11.002_bb0150","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0197-4580(02)00019-2","article-title":"Oxidative stress in brain aging: implications for therapeutics of neurodegenerative diseases","volume":"23","author":"Floyd","year":"2002","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1016\/j.nutres.2016.11.002_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diabetes.52.1.1","article-title":"Are Oxidative Stress\u2212 Activated Signaling Pathways Mediators of Insulin Resistance and \u03b2-Cell Dysfunction?","volume":"52","author":"Evans","year":"2003","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.nutres.2016.11.002_bb0160","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1074\/jbc.M703753200","article-title":"Leptin-mediated cell survival signaling in hippocampal neurons mediated by JAK STAT3 and mitochondrial stabilization","volume":"283","author":"Guo","year":"2008","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.nutres.2016.11.002_bb0165","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00125-004-1627-9","article-title":"Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients","volume":"48","author":"Anello","year":"2005","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.nutres.2016.11.002_bb0170","doi-asserted-by":"crossref","first-page":"E731","DOI":"10.1152\/ajpendo.00159.2011","article-title":"Tissue-specific control of mitochondrial respiration in obesity-related insulin resistance and diabetes","volume":"302","author":"Holmstr\u00f6m","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.nutres.2016.11.002_bb0175","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.bbadis.2014.06.010","article-title":"Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain","volume":"1842","author":"Butterfield","year":"2014","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"issue":"4","key":"10.1016\/j.nutres.2016.11.002_bb0180","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s00125-008-1255-x","article-title":"Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis","volume":"52","author":"Zraika","year":"2009","journal-title":"Diabetologia"},{"issue":"s176","key":"10.1016\/j.nutres.2016.11.002_bb0185","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1034\/j.1600-0404.2000.00308.x","article-title":"Acetylcholinesterase\u2013amyloid\u2010\u03b2\u2010peptide interaction and Wnt signaling involvement in A\u03b2 neurotoxicity","volume":"102","author":"Inestrosa","year":"2000","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"10.1016\/j.nutres.2016.11.002_bb0190","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1152\/japplphysiol.01064.2013","article-title":"Exercise training decreases activation of the mitochondrial fission protein dynamin-related protein-1 in insulin-resistant human skeletal muscle","volume":"117","author":"Fealy","year":"2014","journal-title":"J Appl Physiol"},{"issue":"11","key":"10.1016\/j.nutres.2016.11.002_bb0195","doi-asserted-by":"crossref","first-page":"E1373","DOI":"10.1152\/ajpendo.00500.2011","article-title":"Increased A\u03b2 production prompts the onset of glucose intolerance and insulin resistance","volume":"302","author":"Jim\u00e9nez-Palomares","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"19","key":"10.1016\/j.nutres.2016.11.002_bb0200","doi-asserted-by":"crossref","first-page":"14077","DOI":"10.1074\/jbc.275.19.14077","article-title":"Alzheimer's \u03b2-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line","volume":"275","author":"Kawahara","year":"2000","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.nutres.2016.11.002_bb0205","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI200525102","article-title":"Inflammation, stress, and diabetes","volume":"115","author":"Wellen","year":"2005","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.nutres.2016.11.002_bb0210","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2337\/db06-0263","article-title":"Adipose tissue from lipid storage compartment to endocrine organ","volume":"55","author":"Scherer","year":"2006","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.nutres.2016.11.002_bb0215","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.nutres.2016.11.002_bb0220","doi-asserted-by":"crossref","first-page":"E1003","DOI":"10.1152\/ajpendo.90377.2008","article-title":"Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet","volume":"296","author":"Posey","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.nutres.2016.11.002_bb0225","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1073\/pnas.93.8.3492","article-title":"Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide","volume":"93","author":"Verchere","year":"1996","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"10.1016\/j.nutres.2016.11.002_bb0230","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s001250051175","article-title":"Extensive islet amyloid formation is induced by development of type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model","volume":"42","author":"H\u00f6ppener","year":"1999","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.nutres.2016.11.002_bb0235","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.molmed.2005.02.009","article-title":"Alzheimer's disease: A\u03b2, tau and synaptic dysfunction","volume":"11","author":"LaFerla","year":"2005","journal-title":"Trends Mol Med"},{"issue":"3","key":"10.1016\/j.nutres.2016.11.002_bb0240","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jalz.2015.02.003","article-title":"2015 Alzheimer's disease facts and figures","volume":"11","author":"Alzheimer's","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.nutres.2016.11.002_bb0245","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s004060050101","article-title":"Clinical features of Alzheimer\u2019s disease","volume":"249","author":"F\u00f6rstl","year":"1999","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"3","key":"10.1016\/j.nutres.2016.11.002_bb0250","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/0006-291X(84)91209-9","article-title":"Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein","volume":"122","author":"Glenner","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.nutres.2016.11.002_bb0255","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3233\/JAD-2009-0972","article-title":"An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease","volume":"16","author":"Moreira","year":"2009","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10.1016\/j.nutres.2016.11.002_bb0260","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3233\/JAD-2006-9207","article-title":"Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease","volume":"9","author":"Zhu","year":"2006","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.nutres.2016.11.002_bb0265","doi-asserted-by":"crossref","first-page":"225","DOI":"10.59566\/IJBS.2010.6225","article-title":"Oxidative stress and its implications for future treatments and management of Alzheimer disease","volume":"6","author":"Clark","year":"2010","journal-title":"Int J Biomed Sci"},{"key":"10.1016\/j.nutres.2016.11.002_bb0270","first-page":"3","article-title":"Neuropathologic changes in Alzheimer's disease: potential targets for treatment","volume":"67","author":"Wenk","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"10.1016\/j.nutres.2016.11.002_bb0275","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1212\/01.wnl.0000176061.33817.90","article-title":"Change in body mass index and risk of incident Alzheimer disease","volume":"65","author":"Buchman","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.nutres.2016.11.002_bb0280","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/archneurol.2008.582","article-title":"Midlife and late-life obesity and the risk of dementia: cardiovascular health study","volume":"66","author":"Fitzpatrick","year":"2009","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.nutres.2016.11.002_bb0285","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/WAD.0b013e318222f0d4","article-title":"Central obesity in the elderly is related to late onset Alzheimer\u2019s disease","volume":"26","author":"Luchsinger","year":"2012","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"3","key":"10.1016\/j.nutres.2016.11.002_bb0290","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajpath.2014.11.016","article-title":"In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease","volume":"185","author":"Oskarsson","year":"2015","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.nutres.2016.11.002_bb0295","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3233\/JAD-2005-8304","article-title":"Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine","volume":"8","author":"Rivera","year":"2005","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.nutres.2016.11.002_bb0300","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.nutres.2016.11.002_bb0305","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)63822-9","article-title":"Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-\u03b54 allele","volume":"162","author":"Cook","year":"2003","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.nutres.2016.11.002_bb0310","first-page":"245","article-title":"Impaired glucose tolerance is associated with increased islet amyloid polypeptide (IAPP) immunoreactivity in pancreatic beta cells","volume":"135","author":"Johnson","year":"1989","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.nutres.2016.11.002_bb0315","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJM198908243210806","article-title":"Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus","volume":"321","author":"Johnson","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nutres.2016.11.002_bb0320","first-page":"1","article-title":"Pramlintide Antagonizes Beta Amyloid (A\u03b2)-and Human Amylin-Induced Depression of Hippocampal Long-Term Potentiation","author":"Kimura","year":"2016","journal-title":"Mol Neurobiol"},{"issue":"2","key":"10.1016\/j.nutres.2016.11.002_bb0325","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2337\/diab.40.2.280","article-title":"Influence of dietary fat composition on development of insulin resistance in rats: relationship to muscle triglyceride and \u03c9-3 fatty acids in muscle phospholipid","volume":"40","author":"Storlien","year":"1991","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.nutres.2016.11.002_bb0330","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2337\/diab.40.11.1397","article-title":"Development of muscle insulin resistance after liver insulin resistance in high-fat\u2013fed rats","volume":"40","author":"Kraegen","year":"1991","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.nutres.2016.11.002_bb0335","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/oby.2010.248","article-title":"The relationship of waist circumference and BMI to visceral, subcutaneous, and total body fat: sex and race differences","volume":"19","author":"Camhi","year":"2011","journal-title":"Obesity"},{"issue":"5","key":"10.1016\/j.nutres.2016.11.002_bb0340","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00007256-200030050-00002","article-title":"Insulin resistance with aging","volume":"30","author":"Ryan","year":"2000","journal-title":"Sports Med"},{"issue":"1","key":"10.1016\/j.nutres.2016.11.002_bb0345","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/diab.46.1.3","article-title":"Role of fatty acids in the pathogenesis of insulin resistance and NIDDM","volume":"46","author":"Boden","year":"1997","journal-title":"Diabetes"},{"issue":"5622","key":"10.1016\/j.nutres.2016.11.002_bb0350","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1126\/science.1082889","article-title":"Mitochondrial dysfunction in the elderly: possible role in insulin resistance","volume":"300","author":"Petersen","year":"2003","journal-title":"Science"},{"issue":"7121","key":"10.1016\/j.nutres.2016.11.002_bb0355","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes","volume":"444","author":"Kahn","year":"2006","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.nutres.2016.11.002_bb0360","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid \u03b2-protein, and the \u03b2-amyloid precursor protein intracellular domain in vivo","volume":"100","author":"Farris","year":"2003","journal-title":"Proc Natl Acad Sci"},{"issue":"9","key":"10.1016\/j.nutres.2016.11.002_bb0365","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0196-9781(97)00231-3","article-title":"Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin","volume":"18","author":"Banks","year":"1997","journal-title":"Peptides"},{"issue":"8","key":"10.1016\/j.nutres.2016.11.002_bb0370","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0196-9781(97)00198-8","article-title":"Selective, physiological transport of insulin across the blood-brain barrier: novel demonstration by species-specific radioimmunoassays","volume":"18","author":"Banks","year":"1997","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.nutres.2016.11.002_bb0375","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1172\/JCI116773","article-title":"Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain","volume":"92","author":"Baura","year":"1993","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.nutres.2016.11.002_bb0380","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1210\/jcem-64-1-190","article-title":"Cerebrospinal Fluid Insulin Levels Increase During Intravenous Insulin Infusions in Man*","volume":"64","author":"Wallum","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"issue":"4-5","key":"10.1016\/j.nutres.2016.11.002_bb0385","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s007020050067","article-title":"Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis","volume":"105","author":"Hoyer","year":"1998","journal-title":"J Neural Transm"},{"issue":"1","key":"10.1016\/j.nutres.2016.11.002_bb0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02251132","article-title":"Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases","volume":"3","author":"Hoyer","year":"1991","journal-title":"J Neural Transm Park Dis Dement Sect"},{"issue":"2","key":"10.1016\/j.nutres.2016.11.002_bb0395","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tem.2005.01.008","article-title":"The role of insulin receptor signaling in the brain","volume":"16","author":"Plum","year":"2005","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.nutres.2016.11.002_bb0400","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease\u2013is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10.1016\/j.nutres.2016.11.002_bb0405","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/MCB.05603-11","article-title":"Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle","volume":"32","author":"Jheng","year":"2012","journal-title":"Mol Cell Biol"},{"issue":"5","key":"10.1016\/j.nutres.2016.11.002_bb0410","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1210\/en.2003-1336","article-title":"Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans","volume":"145","author":"Fain","year":"2004","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.nutres.2016.11.002_bb0415","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2337\/diab.37.8.1020","article-title":"Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.nutres.2016.11.002_bb0420","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","article-title":"Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance","volume":"112","author":"Xu","year":"2003","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.nutres.2016.11.002_bb0425","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.it.2003.10.013","article-title":"Inflammation: the link between insulin resistance, obesity and diabetes","volume":"25","author":"Dandona","year":"2004","journal-title":"Trends Immunol"},{"issue":"4","key":"10.1016\/j.nutres.2016.11.002_bb0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005045","article-title":"High-fat diet induces apoptosis of hypothalamic neurons","volume":"4","author":"Moraes","year":"2009","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.nutres.2016.11.002_bb0435","first-page":"608","article-title":"Insulin degradation: progress and potential 1","volume":"19","author":"Duckworth","year":"1998","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.nutres.2016.11.002_bb0440","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2337\/diab.33.1.64","article-title":"Degradation of insulin by isolated mouse pancreatic acini: evidence for cell surface protease activity","volume":"33","author":"Goldfine","year":"1984","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.nutres.2016.11.002_bb0445","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/bbrc.1997.6066","article-title":"Overexpression of insulin degrading enzyme: cellular localization and effects on insulin signaling","volume":"231","author":"Seta","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.nutres.2016.11.002_bb0450","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1523\/JNEUROSCI.20-05-01657.2000","article-title":"Neurons regulate extracellular levels of amyloid \u03b2-protein via proteolysis by insulin-degrading enzyme","volume":"20","author":"Vekrellis","year":"2000","journal-title":"J Neurosci"},{"issue":"7","key":"10.1016\/j.nutres.2016.11.002_bb0455","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/jnr.20809","article-title":"Insulin degrading enzyme is localized predominantly at the cell surface of polarized and unpolarized human cerebrovascular endothelial cell cultures","volume":"83","author":"Lynch","year":"2006","journal-title":"J Neurosci Res"},{"issue":"47","key":"10.1016\/j.nutres.2016.11.002_bb0460","doi-asserted-by":"crossref","first-page":"36621","DOI":"10.1074\/jbc.M006170200","article-title":"Degradation of amylin by insulin-degrading enzyme","volume":"275","author":"Bennett","year":"2000","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.nutres.2016.11.002_bb0465","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0968-0004(01)01876-X","article-title":"Insulin-degrading enzyme: embarking on amyloid destruction","volume":"26","author":"Kurochkin","year":"2001","journal-title":"Trends Biochem Sci"},{"issue":"6","key":"10.1016\/j.nutres.2016.11.002_bb0470","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2337\/diabetes.52.6.1562","article-title":"Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study","volume":"52","author":"Karamohamed","year":"2003","journal-title":"Diabetes"},{"issue":"7130","key":"10.1016\/j.nutres.2016.11.002_bb0475","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05616","article-title":"A genome-wide association study identifies novel risk loci for type 2 diabetes","volume":"445","author":"Sladek","year":"2007","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.nutres.2016.11.002_bb0480","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000097300","article-title":"Insulin-degrading enzyme haplotypes affect insulin levels but not dementia risk","volume":"3","author":"Marlowe","year":"2007","journal-title":"Neurodegener Dis"},{"issue":"4-5","key":"10.1016\/j.nutres.2016.11.002_bb0485","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s11064-006-9125-8","article-title":"Systemic and brain metabolic dysfunction as a new paradigm for approaching Alzheimer\u2019s dementia","volume":"32","author":"Giordano","year":"2007","journal-title":"Neurochem Res"},{"issue":"3","key":"10.1016\/j.nutres.2016.11.002_bb0490","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3233\/JAD-150307","article-title":"Central nervous system delivery of intranasal insulin: mechanisms of uptake and effects on cognition","volume":"47","author":"Salameh","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.nutres.2016.11.002_bb0495","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch Neurol"},{"issue":"12","key":"10.1016\/j.nutres.2016.11.002_bb0500","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s40263-014-0214-y","article-title":"A single-dose pilot trial of intranasal rapid-acting insulin in apolipoprotein E4 carriers with mild\u2013moderate Alzheimer\u2019s disease","volume":"28","author":"Rosenbloom","year":"2014","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1016\/j.nutres.2016.11.002_bb0505","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ncpendmet0196","article-title":"Drug Insight: the role of leptin in human physiology and pathophysiology\u2014emerging clinical applications","volume":"2","author":"Brennan","year":"2006","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"10.1016\/j.nutres.2016.11.002_bb0510","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199602013340503","article-title":"Serum immunoreactive-leptin concentrations in normal-weight and obese humans","volume":"334","author":"Considine","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nutres.2016.11.002_bb0515","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.physiol.70.113006.100707","article-title":"Mechanisms of leptin action and leptin resistance","volume":"70","author":"Myers","year":"2008","journal-title":"Annu Rev Physiol"},{"issue":"8","key":"10.1016\/j.nutres.2016.11.002_bb0520","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1210\/endo.139.8.6154","article-title":"Expression of leptin receptor isoforms in rat brain microvessels","volume":"139","author":"Bj\u00f8rb\u00e6k","year":"1998","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.nutres.2016.11.002_bb0525","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/(SICI)1096-9861(19980615)395:4<535::AID-CNE9>3.0.CO;2-2","article-title":"Distributions of leptin receptor mRNA isoforms in the rat brain","volume":"395","author":"Elmquist","year":"1998","journal-title":"J Comp Neurol"},{"issue":"13","key":"10.1016\/j.nutres.2016.11.002_bb0530","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1073\/pnas.94.13.7001","article-title":"Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues","volume":"94","author":"Fei","year":"1997","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"10.1016\/j.nutres.2016.11.002_bb0535","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.2337\/diabetes.51.4.1016","article-title":"Leptin resistance during aging is independent of fat mass","volume":"51","author":"Gabriely","year":"2002","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.nutres.2016.11.002_bb0540","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.physbeh.2008.04.020","article-title":"Differential leptin access into the brain\u2014a hierarchical organization of hypothalamic leptin target sites?","volume":"94","author":"M\u00fcnzberg","year":"2008","journal-title":"Physiol Behav"},{"issue":"49","key":"10.1016\/j.nutres.2016.11.002_bb0545","doi-asserted-by":"crossref","first-page":"19476","DOI":"10.1073\/pnas.0706671104","article-title":"Silencing of OB-RGRP in mouse hypothalamic arcuate nucleus increases leptin receptor signaling and prevents diet-induced obesity","volume":"104","author":"Couturier","year":"2007","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"10.1016\/j.nutres.2016.11.002_bb0550","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3233\/JAD-2009-1021","article-title":"Leptin: a novel therapeutic strategy for Alzheimer's disease","volume":"16","author":"Tezapsidis","year":"2009","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.nutres.2016.11.002_bb0555","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000054536","article-title":"The long form of the leptin receptor (OB-Rb) is widely expressed in the human brain","volume":"71","author":"Burguera","year":"2000","journal-title":"Neuroendocrinology"},{"issue":"4","key":"10.1016\/j.nutres.2016.11.002_bb0560","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.mcn.2007.05.001","article-title":"Leptin promotes rapid dynamic changes in hippocampal dendritic morphology","volume":"35","author":"O\u2019Malley","year":"2007","journal-title":"Mol Cell Neurosci"},{"issue":"18","key":"10.1016\/j.nutres.2016.11.002_bb0565","doi-asserted-by":"crossref","first-page":"12950","DOI":"10.1074\/jbc.M508691200","article-title":"Leptin increases axonal growth cone size in developing mouse cortical neurons by convergent signals inactivating glycogen synthase kinase-3\u03b2","volume":"281","author":"Valerio","year":"2006","journal-title":"J Biol Chem"},{"issue":"26","key":"10.1016\/j.nutres.2016.11.002_bb0570","doi-asserted-by":"crossref","first-page":"18238","DOI":"10.1074\/jbc.M800053200","article-title":"Leptin increases adult hippocampal neurogenesis in vivo and in vitro","volume":"283","author":"Garza","year":"2008","journal-title":"J Biol Chem"},{"issue":"5667","key":"10.1016\/j.nutres.2016.11.002_bb0575","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1126\/science.1095004","article-title":"Trophic action of leptin on hypothalamic neurons that regulate feeding","volume":"304","author":"Bouret","year":"2004","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.nutres.2016.11.002_bb0580","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1471-4159.2008.05645.x","article-title":"Leptin protects hippocampal CA1 neurons against ischemic injury","volume":"107","author":"Zhang","year":"2008","journal-title":"J Neurochem"},{"issue":"8","key":"10.1016\/j.nutres.2016.11.002_bb0585","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1161\/STROKEAHA.107.482786","article-title":"Neuroprotective effects of leptin against ischemic injury induced by oxygen-glucose deprivation and transient cerebral ischemia","volume":"38","author":"Zhang","year":"2007","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.nutres.2016.11.002_bb0590","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1113\/jphysiol.2002.029488","article-title":"Leptin inhibits epileptiform\u2010like activity in rat hippocampal neurones via PI 3\u2010kinase\u2010driven activation of BK channels","volume":"545","author":"Shanley","year":"2002","journal-title":"J Physiol"},{"issue":"4","key":"10.1016\/j.nutres.2016.11.002_bb0595","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.neuroscience.2008.04.052","article-title":"Neuroprotective actions of leptin on central and peripheral neurons in vitro","volume":"154","author":"Doherty","year":"2008","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.nutres.2016.11.002_bb0600","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1161\/STROKEAHA.108.528588","article-title":"Leptin Is Induced in the Ischemic Cerebral Cortex and Exerts Neuroprotection Through NF-\u03baB\/c-Rel\u2013Dependent Transcription","volume":"40","author":"Valerio","year":"2009","journal-title":"Stroke"},{"issue":"47","key":"10.1016\/j.nutres.2016.11.002_bb0605","doi-asserted-by":"crossref","first-page":"34479","DOI":"10.1074\/jbc.M705426200","article-title":"Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling","volume":"282","author":"Weng","year":"2007","journal-title":"J Biol Chem"},{"issue":"24","key":"10.1016\/j.nutres.2016.11.002_bb0610","doi-asserted-by":"crossref","first-page":"RC186","DOI":"10.1523\/JNEUROSCI.21-24-j0001.2001","article-title":"Leptin enhances NMDA receptor function and modulates hippocampal synaptic plasticity","volume":"21","author":"Shanley","year":"2001","journal-title":"J Neurosci"},{"issue":"23","key":"10.1016\/j.nutres.2016.11.002_bb0615","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1001\/jama.2009.1836","article-title":"Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging","volume":"302","author":"Lieb","year":"2009","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.nutres.2016.11.002_bb0620","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.neurobiolaging.2007.11.024","article-title":"Serum leptin level and cognition in the elderly: findings from the Health ABC Study","volume":"30","author":"Holden","year":"2009","journal-title":"Neurobiol Aging"},{"issue":"5","key":"10.1016\/j.nutres.2016.11.002_bb0625","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020286","article-title":"Adipocytokines and CD34+ progenitor cells in Alzheimer's disease","volume":"6","author":"Bigalke","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.nutres.2016.11.002_bb0630","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/jnc.12380","article-title":"Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance","volume":"128","author":"Bonda","year":"2014","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.nutres.2016.11.002_bb0635","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neulet.2009.03.066","article-title":"Leptin inhibits glycogen synthase kinase-3\u03b2 to prevent tau phosphorylation in neuronal cells","volume":"455","author":"Greco","year":"2009","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.nutres.2016.11.002_bb0640","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bbrc.2009.01.041","article-title":"Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells","volume":"380","author":"Greco","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.nutres.2016.11.002_bb0645","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.bbrc.2008.09.026","article-title":"Leptin reduces Alzheimer\u2019s disease-related tau phosphorylation in neuronal cells","volume":"376","author":"Greco","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.nutres.2016.11.002_bb0650","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.nbd.2006.12.019","article-title":"Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease","volume":"26","author":"Halagappa","year":"2007","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1016\/j.nutres.2016.11.002_bb0655","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neulet.2009.08.038","article-title":"Caloric restriction attenuates amyloid deposition in middle-aged dtg APP\/PS1 mice","volume":"464","author":"Mouton","year":"2009","journal-title":"Neurosci Lett"},{"issue":"7","key":"10.1016\/j.nutres.2016.11.002_bb0660","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.neurobiolaging.2004.09.014","article-title":"Caloric restriction attenuates A\u03b2-deposition in Alzheimer transgenic models","volume":"26","author":"Patel","year":"2005","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1016\/j.nutres.2016.11.002_bb0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-7075-2-28","article-title":"A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease","volume":"2","author":"Van Der Auwera","year":"2005","journal-title":"Nutr Metab"},{"issue":"6","key":"10.1016\/j.nutres.2016.11.002_bb0670","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.04-3182fje","article-title":"Caloric restriction attenuates \u03b2-amyloid neuropathology in a mouse model of Alzheimer\u2019s disease","volume":"19","author":"Wang","year":"2005","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.nutres.2016.11.002_bb0675","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3233\/JAD-2010-1308","article-title":"Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease","volume":"19","author":"Greco","year":"2010","journal-title":"J Alzheimers Dis"},{"issue":"20","key":"10.1016\/j.nutres.2016.11.002_bb0680","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1073\/pnas.0706473105","article-title":"Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies","volume":"105","author":"Roth","year":"2008","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"10.1016\/j.nutres.2016.11.002_bb0685","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1210\/en.2008-0770","article-title":"Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms","volume":"149","author":"Trevaskis","year":"2008","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.nutres.2016.11.002_bb0690","first-page":"R1442","article-title":"Histamine H1 receptors mediate the anorectic action of the pancreatic hormone amylin","volume":"281","author":"Mollet","year":"2001","journal-title":"Am J Phys Regul Integr Comp Phys"},{"issue":"1","key":"10.1016\/j.nutres.2016.11.002_bb0695","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.physbeh.2011.04.044","article-title":"Influence of high-fat feeding, diet-induced obesity, and hyperamylinemia on the sensitivity to acute amylin","volume":"104","author":"Boyle","year":"2011","journal-title":"Physiol Behav"},{"issue":"4","key":"10.1016\/j.nutres.2016.11.002_bb0700","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.physbeh.2006.04.001","article-title":"Amylinergic control of food intake","volume":"89","author":"Lutz","year":"2006","journal-title":"Physiol Behav"},{"issue":"5","key":"10.1016\/j.nutres.2016.11.002_bb0705","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2337\/dc07-2433","article-title":"Leptin does not directly regulate the pancreatic hormones amylin and pancreatic polypeptide Interventional studies in humans","volume":"31","author":"Hwang","year":"2008","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.nutres.2016.11.002_bb0710","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0026-0495(97)90170-0","article-title":"Dose-response for glucagonostatic effect of amylin in rats","volume":"46","author":"Gedulin","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.nutres.2016.11.002_bb0715","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1054-3589(05)52006-4","article-title":"Inhibition of gastric emptying","volume":"52","author":"Young","year":"2005","journal-title":"Adv Pharmacol"},{"issue":"11","key":"10.1016\/j.nutres.2016.11.002_bb0720","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1464-5491.2004.01319.x","article-title":"Amylin replacement with pramlintide as an adjunct to insulin therapy improves long\u2010term glycaemic and weight control in Type 1 diabetes mellitus: a 1\u2010year, randomized controlled trial","volume":"21","author":"Ratner","year":"2004","journal-title":"Diabet Med"},{"issue":"48","key":"10.1016\/j.nutres.2016.11.002_bb0725","doi-asserted-by":"crossref","first-page":"17401","DOI":"10.1523\/JNEUROSCI.3028-12.2012","article-title":"Beta amyloid-induced depression of hippocampal long-term potentiation is mediated through the amylin receptor","volume":"32","author":"Kimura","year":"2012","journal-title":"J Neurosci"},{"issue":"8","key":"10.1016\/j.nutres.2016.11.002_bb0730","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1210\/jc.2004-0405","article-title":"Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes","volume":"89","author":"Hull","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.nutres.2016.11.002_bb0735","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1006\/jmbi.2001.5244","article-title":"Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity","volume":"315","author":"Kapurniotu","year":"2002","journal-title":"J Mol Biol"},{"issue":"38","key":"10.1016\/j.nutres.2016.11.002_bb0740","first-page":"1","article-title":"Lessons from two prevalent amyloidoses\u2014what amylin and A\u03b2 have in common","volume":"5","author":"Gotz","year":"2013","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"10.1016\/j.nutres.2016.11.002_bb0745","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00134-002-1224-7","article-title":"Amylin is associated with delayed gastric emptying in critically ill children","volume":"28","author":"Mayer","year":"2002","journal-title":"Intensive Care Med"},{"issue":"22","key":"10.1016\/j.nutres.2016.11.002_bb0750","doi-asserted-by":"crossref","first-page":"18820","DOI":"10.1074\/jbc.M111.331181","article-title":"Amyloid \u03b2 (A\u03b2) peptide directly activates amylin-3 receptor subtype by triggering multiple intracellular signaling pathways","volume":"287","author":"Fu","year":"2012","journal-title":"J Biol Chem"},{"issue":"6703","key":"10.1016\/j.nutres.2016.11.002_bb0755","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/27208","article-title":"Destabilization of \u03b2-catenin by mutations in presenilin-1 potentiates neuronal apoptosis","volume":"395","author":"Zhang","year":"1998","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.nutres.2016.11.002_bb0760","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0925-4439(00)00028-4","article-title":"Presenilin structure, function and role in Alzheimer disease","volume":"1502","author":"Fraser","year":"2000","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"issue":"36","key":"10.1016\/j.nutres.2016.11.002_bb0765","doi-asserted-by":"crossref","first-page":"7783","DOI":"10.1021\/bi100337p","article-title":"Selection for nonamyloidogenic mutants of islet amyloid polypeptide (IAPP) identifies an extended region for amyloidogenicity","volume":"49","author":"Fox","year":"2010","journal-title":"Biochemistry"},{"issue":"Suppl. 2","key":"10.1016\/j.nutres.2016.11.002_bb0770","first-page":"235A","article-title":"The selection of pramlintide for clinical evaluation","volume":"45","author":"Janes","year":"1996","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.nutres.2016.11.002_bb0775","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1098-2299(199604)37:4<231::AID-DDR5>3.0.CO;2-M","article-title":"Preclinical pharmacology of pramlintide in the rat: comparisons with human and rat amylin","volume":"37","author":"Young","year":"1996","journal-title":"Drug Dev Res"},{"issue":"3","key":"10.1016\/j.nutres.2016.11.002_bb0780","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2337\/diacare.26.3.784","article-title":"Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes a 1-year randomized controlled trial","volume":"26","author":"Hollander","year":"2003","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.nutres.2016.11.002_bb0785","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1073\/pnas.92.6.1989","article-title":"Amyloid peptides are toxic via a common oxidative mechanism","volume":"92","author":"Schubert","year":"1995","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"10.1016\/j.nutres.2016.11.002_bb0790","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/nn.2198","article-title":"\u03b2-catenin is required for memory consolidation","volume":"11","author":"Maguschak","year":"2008","journal-title":"Nat Neurosci"},{"issue":"4","key":"10.1016\/j.nutres.2016.11.002_bb0795","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.neurobiolaging.2013.10.076","article-title":"Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition","volume":"35","author":"Adler","year":"2014","journal-title":"Neurobiol Aging"},{"issue":"3","key":"10.1016\/j.nutres.2016.11.002_bb0800","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2337\/diacare.28.3.632","article-title":"Effects of pramlintide on postprandial glucose excursions and measures of oxidative stress in patients with type 1 diabetes","volume":"28","author":"Ceriello","year":"2005","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.nutres.2016.11.002_bb0805","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1042\/BJ20110512","article-title":"Reduction in BACE1 decreases body weight, protects against diet-induced obesity and enhances insulin sensitivity in mice","volume":"441","author":"Meakin","year":"2012","journal-title":"Biochem J"},{"issue":"7","key":"10.1016\/j.nutres.2016.11.002_bb0810","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00125-016-3960-1","article-title":"Neuronal human BACE1 knockin induces systemic diabetes in mice","volume":"59","author":"Plucinska","year":"2016","journal-title":"Diabetologia"}],"container-title":["Nutrition Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0271531716302755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0271531716302755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T12:48:00Z","timestamp":1718887680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0271531716302755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":162,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0271531716302755"],"URL":"https:\/\/doi.org\/10.1016\/j.nutres.2016.11.002","relation":{},"ISSN":["0271-5317"],"issn-type":[{"value":"0271-5317","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Nutrition Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nutres.2016.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}